Compounds > galactose
Page last updated: 2024-08-17

galactose and Bone Diseases, Metabolic

galactose has been researched along with Bone Diseases, Metabolic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Cerone, J; Rios, A1
Gao, R; Hu, M; Jiang, H; Lin, T; Ma, J; Meng, Y; Shu, L; Wang, C; Zhang, Z; Zhou, X1
Bonanno, M; Bryk, G; Pita Martín de Portela, ML; Río, ME; Seijo, M; Zeni Coronel, M; Zeni, SN1
Inaba, M; Morii, H; Nishizawa, Y; Shioi, A1
Inaba, M; Ishimura, E; Morii, H; Nishizawa, Y; Otani, S; Shioi, A; Terada, M1

Other Studies

5 other study(ies) available for galactose and Bone Diseases, Metabolic

ArticleYear
Galactosemia.
    Pediatrics in review, 2019, Volume: 40, Issue:Suppl 1

    Topics: Bone Density; Bone Diseases, Metabolic; Developmental Disabilities; Female; Galactose; Galactosemias; Growth Disorders; Humans; Infant, Newborn; Neonatal Screening; Primary Ovarian Insufficiency

2019
FOS/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice.
    Metabolism: clinical and experimental, 2021, Volume: 119

    Topics: Animals; Bone Diseases, Metabolic; Cells, Cultured; Diet, High-Fat; Dysbiosis; Galactose; Gastrointestinal Microbiome; Inflammation; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Oligosaccharides; Permeability

2021
Effect of Adding a Galacto-Oligosaccharides/Fructo-Oligosaccharides (GOS/FOS®) Mixture to a Normal and Low Calcium Diet, on Calcium Absorption and Bone Health in Ovariectomy-Induced Osteopenic Rats.
    Calcified tissue international, 2019, Volume: 104, Issue:3

    Topics: Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Calcium, Dietary; Diet; Dietary Supplements; Female; Fructose; Galactose; Intestinal Absorption; Oligosaccharides; Ovariectomy; Rats; Rats, Wistar

2019
Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1997, Volume: 7 Suppl 3

    Topics: Aldehyde Reductase; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcitriol; Cells, Cultured; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Galactose; Glucose; Humans; Hypercalcemia; Hypoglycemic Agents; Male; Middle Aged; Osteoblasts; Parathyroid Hormone; Rats

1997
Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism.
    Metabolism: clinical and experimental, 1999, Volume: 48, Issue:7

    Topics: Aldehyde Reductase; Amino Acids; Animals; Blood Glucose; Body Weight; Bone and Bones; Bone Diseases, Metabolic; Calcium; Eating; Enzyme Inhibitors; Galactose; Male; Osteocalcin; Polymers; Rats; Rats, Wistar; Rhodanine; Thiazolidines; Tibia

1999